rewirebio.iobenchmarks
Source

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

2024 final article; reported VCEP specifications v1.0 · Peer-reviewed

DOI: 10.1016/j.ajhg.2024.07.013Original source

What this source contributed

Records in this release that cite this source. A record can cite several sources.

Results

Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.

Model or configurationMetricValueDatasetEvaluation
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: high, benign)149 countBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: high, pathogenic)377 countBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: low, benign)946 countBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: low, pathogenic)34 countBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: middle, benign)183 countBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: middle, pathogenic)45 countBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesLikelihood ratio (interval: high)7.09 unitlessBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesLikelihood ratio (interval: low)0.10 unitlessBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesLikelihood ratio (interval: middle)0.69 unitlessBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: high, benign)12% percentBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: high, pathogenic)83% percentBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: low, benign)74% percentBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: low, pathogenic)7% percentBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: middle, benign)14% percentBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: middle, pathogenic)10% percentBRCA1 functional reference calibration setBRCA1 BayesDel gene-specific calibration
BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProportion (benign reference variants assigned BP4)<10% percentBRCA1 functional reference calibration setBRCA1 generic BayesDel threshold comparator
BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProportion (benign reference variants assigned PP3)29% percentBRCA1 functional reference calibration setBRCA1 generic BayesDel threshold comparator
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: high, benign)29 countBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: high, pathogenic)88 countBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: low, benign)216 countBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: low, pathogenic)21 countBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: middle, benign)46 countBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesCount (interval: middle, pathogenic)25 countBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesLikelihood ratio (interval: high)6.59 unitlessBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesLikelihood ratio (interval: low)0.21 unitlessBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesLikelihood ratio (interval: middle)1.18 unitlessBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: high, benign)10% percentBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: high, pathogenic)66% percentBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: low, benign)74% percentBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: low, pathogenic)16% percentBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: middle, benign)16% percentBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel with ENIGMA BRCA gene-specific score categoriesProportion (interval: middle, pathogenic)19% percentBRCA2 functional reference calibration setBRCA2 BayesDel gene-specific calibration
BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProportion (benign reference variants assigned BP4)<10% percentBRCA2 functional reference calibration setBRCA2 generic BayesDel threshold comparator
BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProportion (benign reference variants assigned PP3)36% percentBRCA2 functional reference calibration setBRCA2 generic BayesDel threshold comparator
ClinGen ENIGMA v1.0 manual criteria-based curationCount (first-phase confidence band)32 countENIGMA 40-variant pilotENIGMA manual specification pilot
ClinGen ENIGMA v1.0 manual criteria-based curationCount (initial VUS conflict resolved)11 countENIGMA 40-variant pilotENIGMA manual specification pilot
ClinGen ENIGMA v1.0 manual criteria-based curationCount (likely benign resolved to benign)3 countENIGMA 40-variant pilotENIGMA manual specification pilot
ClinGen ENIGMA v1.0 manual criteria-based curationCount (likely pathogenic resolved to pathogenic)5 countENIGMA 40-variant pilotENIGMA manual specification pilot
ClinGen ENIGMA v1.0 manual criteria-based curationCount (second-phase VUS or other resolved)6 countENIGMA 40-variant pilotENIGMA manual specification pilot

Claims

Statements this source supports, each with where in the source it was checked.

Models, benchmarks and other records

Methods (1)

Configurations (3)

Benchmarks (1)

Protocols (5)

Datasets (3)

Baselines (2)

Evaluations (5)

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

16 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Artifact retrieved at
2026-09-30T21:24:15Z
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_retrieved_at

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Artifact SHA-256
21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_sha256

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Artifact url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11393667/
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_url

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Doi
10.1016/j.ajhg.2024.07.013
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.doi

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Publication status
peer_reviewed
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.publication_status

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Retrieved at
2026-09-30T21:43:37Z
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.retrieved_at

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11393667/
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.url

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
2024 final article; reported VCEP specifications v1.0
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Primary source inspected for the scoped extraction; automated review does not establish replication.
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Facets: areas
1 values
  • dna-genomes
Source metadata
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

No field-specific location recorded

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

catalogued

No individual claim review recorded

Audit details

Field: facets.areas

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

Primary source inspected for the scoped extraction; automated review does not establish replication.

Release history

No supporting source is linked yet.

Read original source

Download this release (gzip)
Technical metadata and extraction receipts

Stable ID: uc-clinical-20260930-source-enigma

areas
dna-genomes
contexts
clinical_research
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11393667/
retrieved at
2026-09-30T21:43:37Z
version
2024 final article; reported VCEP specifications v1.0
publication status
peer_reviewed
doi
10.1016/j.ajhg.2024.07.013
artifact sha256
21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2
artifact url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11393667/
artifact retrieved at
2026-09-30T21:24:15Z
Related records

    Suggest a correction